The FDA and ABCs

References

1. ↵
   1. Barry Colleen L.,
   2. Busch Susan H.

   2010. “News Coverage of FDA Warnings on Pediatric Antidepressant Use and Suicidality”. Pediatrics 125(1): 88–95.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Berndt Ernst R.,
   2. Koran Lorrin M.,
   3. Finkelstein Stan N.,
   4. Gelenberg Alan J.,
   5. Kornstein Susan G.,
   6. Miller Ivan M.,
   7. Thase Michael E.,
   8. Trapp George A.,
   9. Keller Martin B.

   2000. “Lost Human Capital from Early-Onset Chronic Depression”. American Journal of Psychiatry 157(6): 940–47.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Blanden Jo,
   2. Gregg Paul,
   3. Macmillan Lindsey

   . 2006. “Accounting for Intergenerational Income Persistence: Non-Cognitive Skills, Ability and Education”. Economic Journal 117(519): C43–C60.

   OpenUrl
4. ↵
   1. Borghans Lex,
   2. Duckworth Angela,
   3. Heckman James J.,
   4. Weel Bas ter

   . 2008. “The Economics and Psychology of Personality Traits”. Journal of Human Resources 43(4): 972–1059.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Bowles Samuel,
   2. Gintis Herbert,
   3. Osborne Melissa

   . 2001. “The Determinants of Individual Earnings: Skills, Preferences and Schooling”. Journal of Economic Literature 39(4): 1137–76.

   OpenUrlCrossRefWeb of Science
6. ↵
   1. Breslau Naomi,
   2. Peterson Edward L.,
   3. Schultz Lonni R.,
   4. Chilcoat Howard D.,
   5. Andreski Patricia

   . 1998. “Major Depression and Stages of Smoking. A Longitudinal Investigation”. Archives of General Psychiatry 55(2): 161–66.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Bridge Jeffrey A.,
   2. Greenhouse Joel B.,
   3. Weldon Arielle H.,
   4. Campo John V.,
   5. Kelleher Kelly J.

   2008. “Suicide Trends among Youths Aged 10 to 19 Years in the United States, 1996–2005”. Journal of the American Medical Association 300(9): 1025–26.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Busch Alisa B.,
   2. Huskamp Haiden A.,
   3. Normand Sharon-Lise,
   4. Young Alexander S.,
   5. Goldman Howard,
   6. Frank Richard G.

   2006. “The Impact of Parity on Major Depression Treatment Quality in the Federal Employees’ Health Benefits Program After Parity Implementation”. Medical Care 44(6): 506–12.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Busch Susan H.,
   2. Frank Richard G.,
   3. Leslie Douglas L.,
   4. Martin Andres,
   5. Rosenheck Robert A.,
   6. Martin Erika G.,
   7. Barry Colleen L.

   2010. “Antidepressants and Suicide Risk: How Did Specific Information in FDA Safety Warnings Affect Treatment Patterns?” Psychiatric Services 61(1): 11–16.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Busch Susan H.,
    2. Frank Richard G.,
    3. Martin Andres,
    4. Barry Colleen L.

    2011. “Characterizing Declines in Pediatric Antidepressant Use After New Risk Disclosures”. Medical Care Research and Review 68(1): 96–111.

    OpenUrlCrossRefPubMed
11. ↵
    1. Centers for Disease Control and Prevention, National Center for Health Statistics

    . 2010. Compressed Mortality File (CMF) on CDC WONDER Online Database. Available at http://wonder.cdc.gov/cmficd10.html (accessed March 21, 2011).
12. ↵
    1. Currie Janet,
    2. Stabile Mark

    . 2009. “Mental Health in Childhood and Human Capital,” In The Problems of Disadvantaged Youth: An Economic Perspective, ed. Gruber Jonathan, 115–48. Chicago: University of Chicago Press.
13. ↵
    1. Ding Weili,
    2. Lehrer Steven F.,
    3. Neils Rosenquist J.,
    4. Audrain-McGovern Janet

    . 2009. “The Impact of Poor Health on Academic Performance: New Evidence Using Genetic Markers”. Journal of Health Economics 28(3): 578–97.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Eisenberg Daniel,
    2. Golberstein Ezra,
    3. Hunt Justin B

    . 2009. “Mental Health and Academic Success in College.” B.E. Journal of Economic Analysis & Policy 9(1).
15. ↵
    1. Ettner Susan L.,
    2. Frank Richard G.,
    3. Kessler Ronald C.

    1997. “Impact of Psychiatric Disorder on Labor Market Outcomes”. Industrial and Labor Relations Review 51(1): 64–81.

    OpenUrlCrossRefWeb of Science
16. ↵
    1. Fletcher Jason M

    . 2008. “Adolescent Depression: Diagnosis, Treatment, and Educational Attainment”. Health Economics 17(11): 1215–35.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Gibbons Robert D.,
    2. Hendricks Brown C.,
    3. Hur Kwan,
    4. Marcus Sue M.,
    5. Bhaumik Dsulal K.,
    6. Erkens Joelle A.,
    7. Herings Ron M.C.,
    8. John Mann J.

    2007. “Early Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents”. American Journal of Psychiatry 164(9): 1356–63.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    1. Glantz Meyer D

    . 2002. “Introduction to the Special Issue on the Impact of Childhood Psycho-pathology Interventions on Subsequent Substance Abuse: Pieces of the Puzzle”. Journal of Consulting and Clinical Psychology 70(6): 1203–06.

    OpenUrlCrossRefPubMed
19. ↵
    1. Heckman James J.,
    2. Stixrud Jora,
    3. Urzua Sergio

    . 2006. “The Effects of Cognitive and Noncognitive Abilities on Labor Market Outcomes and Social Behavior”. Journal of Labor Economics 24(3): 411–82.

    OpenUrlCrossRefWeb of Science
20. ↵
    1. Jane-Llopis Eva,
    2. Matytsina Irina

    . 2006. “Mental Health and Alcohol, Drugs and Tobacco: A Review of the Comorbidity Between Mental Disorders and the Use of Alcohol, Tobacco and Illicit Drugs”. Drug and Alcohol Review 25(6): 515–36.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. Kurian Benji T.,
    2. Ray Wayne A.,
    3. Arbogast Patrick G.,
    4. Catherine Fuchs D.,
    5. Dudley Judith A.,
    6. Cooper William O.

    2007. “Effect of Regulatory Warnings on Antidepressant Prescribing for Children and Adolescents”. Archives of Pediatrics & Adolescent Medicine 161(7): 690–96.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    1. Libby Anne M.,
    2. Brent David A.,
    3. Morrato Elaine H.,
    4. Orton Healther D.,
    5. Allen Richard,
    6. Valuck Robert J.

    2007. “Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality with SSRIs”. American Journal of Psychiatry 164(6): 884–91.

    OpenUrlCrossRefPubMedWeb of Science
23. 1. Marcotte Dave E.,
    2. Markowitz Sara

    . 2011. “A Cure for Crime? Psycho-Pharmaceuticals and Crime Trends”. Journal of Policy Analysis and Management 30(1): 29–56.

    OpenUrlCrossRef
24. ↵
    1. Marsh Wendy K.,
    2. Deligiannidis Kristina M.

    2010. “Sex-Related Differences in Anti-depressant Response: When to Adjust Treatment”. Current Psychiatry 9(5): 25–30.

    OpenUrl
25. ↵
    1. Merikangas Kathleen Ries,
    2. He Jian-ping,
    3. Burstein Marcy,
    4. Swanson Sonja A.,
    5. Avenevoli Shelli,
    6. Cui Lihong,
    7. Benjet Corina,
    8. Georgiades Katholiki,
    9. Swendsen Joel

    . 2010. “Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication—Adolescent Supplement (NCS-A)”. Journal of the American Academy of Child and Adolescent Psychiatry 49(10): 980–89.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    1. Nemeroff Charles B.,
    2. Kalali Amir,
    3. Keller Martin B.,
    4. Charney Dennis S.,
    5. Lenderts Susan E.,
    6. Cascade Elisa F.,
    7. Stephenson Hugo,
    8. Schatzberg Alan F.

    2007. “Impact of Publicity Concerning Pediatric Suicidality Data on Physician Practice Patterns in the United States”. Archives of General Psychiatry 64(4): 466–72.

    OpenUrlCrossRefPubMedWeb of Science
27. ↵
    1. Olfson Mark,
    2. Marcus Steven C.,
    3. Druss Benjamin G.

    2008. “Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample”. Archives of General Psychiatry 65(1): 94–101.

    OpenUrlCrossRefPubMedWeb of Science
28. ↵
    1. Olfson Mark,
    2. Marcus Steven C.,
    3. Druss Benjamin G.,
    4. Elinson Lynn,
    5. Tanielian Terri,
    6. Pincus Harold A.

    2002. “National Trends in the Outpatient Treatment of Depression”. Journal of the American Medical Association 287(2): 203–09.

    OpenUrlCrossRefPubMedWeb of Science
29. 1. Olfson Mark,
    2. Marcus Steven C.,
    3. Weissman Myrna M.,
    4. Jensen Peter S.

    2002. “National Trends in the Use of Psychotropic Medications by Children”. Journal of the American Academy of Child Psychiatry 41(5): 514–21.

    OpenUrl
30. ↵
    1. Rosack Jim

    . 2005. “New Data Show Declines in Antidepressant Prescribing”. Psychiatric News 40(17): 1.

    OpenUrl
31. ↵
    1. Rosenthal Meredith B.,
    2. Berndt Ernst R.,
    3. Donohue Julie M.,
    4. Frank Richard G.,
    5. Epstein Arnold M.

    2002. “Promotion of Prescription Drugs to Consumers”. New England Journal of Medicine 346(7): 498–505.

    OpenUrlCrossRefPubMedWeb of Science
32. ↵
    1. Substance Abuse and Mental Health Services Administration (SAMHSA).

    2007. “Depression and the Initiation of Alcohol and Other Drug Use Among Youths Aged 12 to 17”. The NSDUH Report May 3, 2007.
33. ↵
    1. Swendsen Joel,
    2. Conway Kevin P.,
    3. Degenhardt Louisa,
    4. Glantz Myer C.,
    5. Jin Robert,
    6. Merikangas Kathleen R.,
    7. Sampson Nancy,
    8. Kessler Ronald C.

    2010. “Mental Disorders as Risk Factors for Substance Use, Abuse and Dependence: Results from the 10-Year Follow-Up of the National Comorbidity Survey”. Addiction 105(6): 1117–28.

    OpenUrlCrossRefPubMedWeb of Science
34. ↵
    1. Thase Michael E.,
    2. Entsuah Richard,
    3. Cantillon Marc,
    4. Kornstein Susan G.

    2005. “Relative Antidepressant Efficacy of Venlafaxine and SSRIs: Sex-Age Interactions”. Journal of Women’s Health 14(7): 609–16.

    OpenUrlCrossRef
35. ↵
    1. Thomas Cindy Parks,
    2. Conrad Peter,
    3. Casler Rosemary,
    4. Goodman Elizabeth

    . 2006. “Trends in the Use of Psychotropic Drugs Among Adolescents, 1994–2001”. Psychiatric Services 57(1): 63–69.

    OpenUrlCrossRefPubMedWeb of Science
36. ↵
    1. Treatment for Adolescents With Depression Study Team.

    2004. “Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents with Depression: Treatment for Adolescents with Depression Study (TADS) Randomized Controlled Trial”. Journal of the American Medical Association 292(7): 807–20.

    OpenUrlCrossRefPubMedWeb of Science
37. ↵
    1. Valluri Satish,
    2. Zito Julie M.,
    3. Safer Daniel J.,
    4. Zuckerman Ilene H.,
    5. Daniel Mullins C.,
    6. Korelitz James J.

    2010. “Impact of the 2004 Food and Drug Administration Pediatric Suicidality Warning on Antidepressant and Psychotherapy Treatment for New-Onset Depression”. Medical Care 48(11): 947–54.

    OpenUrlCrossRefPubMedWeb of Science
38. ↵
    1. Young Elizabeth A.,
    2. Kornstein Susan G.,
    3. Marcus Sheila M.,
    4. Harvey Anne T.,
    5. Warden Diane,
    6. Wisniewski Stephen R.,
    7. Balasubramani G. K.,
    8. Fava Maurizio,
    9. Trivedi Madhukar A.,
    10. Rush John A.

    2009. “Sex Differences in Response to Citalopram: A STAR*D Report”. Journal of Psychiatric Research 43(5): 503–11.

    OpenUrlCrossRefPubMed